ArticleIJID regions2025
Significance, clinical spectrum, and microbiological evaluation of Actinomyces blood stream infections.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Actinomyces species are Gram-positive anaerobic bacilli that are commensal in the gastrointestinal and genital tracts. Actinomyces blood stream infections (BSIs) are rare but becoming more frequent with advanced diagnostic techniques. The presented study aims to evaluate relevance, clinical and microbiological spectrum of Actinomyces species bacteremia. Methods: A retrospective cohort study was conducted for all reported Actinomyces species BSI between January 2016 to November 2020. Isolates identification and antimicrobial susceptibility tests were performed using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) and BD PhoenixTM automated systems. Results: Overall, 37 episodes of Actinomyces BSIs were recorded, most were Conclusions: Nearly half of the cases were deemed clinically insignificant and responded well to short courses of antimicrobial therapy without long-term consequences. Penicillin and cephalosporins demonstrated superior activity compared to aminoglycosides and quinolones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.